Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.15720
Abstract: Key Points Question How does out-of-pocket spending on and the use of lenalidomide therapy differ between commercially insured patients enrolled in high-deductible health plans (HDHPs) and non-HDHPs? Findings In this cohort study of 3163 adults… read more here.
Keywords: use lenalidomide; lenalidomide therapy; commercially insured; spending use ... See more keywords